These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8074748)
1. Gangliosides and Guillain-Barré syndrome. Science supports the use of gangliosides. Massarotti M; Matano R BMJ; 1994 Mar; 308(6929):654. PubMed ID: 8074748 [No Abstract] [Full Text] [Related]
2. Gangliosides and the Guillain-Barré syndrome. Landi G; Ciccone A; D'Alessandro R; Dossi BC; Ricci S; Simone IL BMJ; 1994 Jun; 308(6944):1638. PubMed ID: 8025444 [No Abstract] [Full Text] [Related]
3. Exposure to exogenous gangliosides and Guillain-Barré syndrome. Beghi E Neuroepidemiology; 1995; 14(2):45-8. PubMed ID: 7891813 [No Abstract] [Full Text] [Related]
4. Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy. Govoni V; Granieri E; Tola MR; Paolino E; Casetta I; Fainardi E; Monetti VC Brain; 1997 Jul; 120 ( Pt 7)():1123-30. PubMed ID: 9236625 [TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome after exogenous gangliosides in Italy. Landi G; D'Alessandro R; Dossi BC; Ricci S; Simone IL; Ciccone A BMJ; 1993 Dec; 307(6917):1463-4. PubMed ID: 8281088 [No Abstract] [Full Text] [Related]
6. [Gangliosides and the Guillain-Barré syndrome]. Berciano J Med Clin (Barc); 1993 Dec; 101(19):758-9. PubMed ID: 8289527 [No Abstract] [Full Text] [Related]
8. Guillain-Barré syndrome and ganglioside therapy in Italy. Raschetti R; Maggini M; Popoli P Lancet; 1992 Jul; 340(8810):60. PubMed ID: 1351644 [No Abstract] [Full Text] [Related]
9. Gangliosides and Guillain-Barré syndrome. Apparent association is a coincidence. Grigoletto F BMJ; 1994 Mar; 308(6929):653-4. PubMed ID: 8148725 [No Abstract] [Full Text] [Related]
10. Gangliosides and Guillain-Barré syndrome. Raschetti R; Maggini M; Popoli P; Caffari B; Da Cas R; Menniti-Ippolito F; Spila-Alegiani S; Traversa G J Clin Epidemiol; 1995 Nov; 48(11):1399-405. PubMed ID: 7490603 [TBL] [Abstract][Full Text] [Related]
15. Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association. Granieri E; Casetta I; Govoni V; Tola MR; Paolino E; Rocca WA Neuroepidemiology; 1991; 10(4):161-9. PubMed ID: 1745325 [TBL] [Abstract][Full Text] [Related]
16. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338 [TBL] [Abstract][Full Text] [Related]
17. Bovine gangliosides and acute motor polyneuropathy. Figueras A; Morales-Olivas FJ; Capellà D; Palop V; Laporte JR BMJ; 1992 Nov; 305(6865):1330-1. PubMed ID: 1309191 [No Abstract] [Full Text] [Related]
19. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome. Yuki N; Takahashi M; Tagawa Y; Kashiwase K; Tadokoro K; Saito K Ann Neurol; 1997 Jul; 42(1):28-33. PubMed ID: 9225682 [TBL] [Abstract][Full Text] [Related]
20. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies]. Tagawa Y; Matsumoto Y; Yuki N No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]